Inhibrx, Inc stock forecast: down to 35.72 USD INBX stock price prognosis

STOCK

Forecast for Fri 17 Dec 2021 price 30.81

Inhibrx, Inc stock price forecast for further price development down to -6.35% (time horizon: 1 day) and price target of 35.72 USD. Short-term (time horizon: 2 weeks) Inhibrx, Inc share price prediction for 2021-12-17 with daily closed price projections

Key Facts

Symbol INBX 

ISIN US45720L1070 

CUSIP 45720L107


Currency USD


Category Biological Products (No Diagnostic Substances)

Forecast price change %

Finance numbers

Revenue 9,566,000.0


Earnings per share -1.43


On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

No maximum tolerated dose, or MTD, was reached. Maintain our culture of innovation, execution and efficiency. These formatting challenges may restrict broad applicability of this technology. It is estimated that as many as 43,000 people worldwide die from mesothelioma each year. It can also form in soft tissues in the lung or abdomen. Gastric AdenocarcinomaGastric cancer is the second most common cancer worldwide. INBRX-106 was found to mediate similar co-stimulation of CD4 and CD8 T-cells. The image below illustrates the unique structure of INBRX-105. However, INBRX-105 does not interact with either mouse PD-L1 or 4-1BB. Exploratory endpoints include NE activity and its biomarkers. We are currently in discussions with Transcenta regarding these matters. The March TSA 35Table of Contentshad a six month term and expired in September 2018. We were reimbursed $0.4 million in October 2018 for the October TSA. Some nonclinical testing may continue even after the IND is submitted. PDUFA also imposes an annual program fee for prescription biological or drug products. The BPCIA is complex and only beginning to be interpreted and implemented by the FDA. Investing in our common stock involves a high degree of risk. As of December 31, 2020, we had an accumulated deficit of $145.4 million. In the event of any such decision, we would be unable to advance such program ourselves. Ultimately, Chiesi may not exercise its option pursuant to the Chiesi Agreement. It is unknown how long these disruptions could continue, were they to occur. Litigation may be necessary to defend against these claims. Our business may be adversely affected as a result of computer system failures. This could lower the price that we receive for any approved product.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1739614/000173961421000047/0001739614-21-000047.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

Institutional ownership list is based on filling form information

Holding name Date Amount
PARAMETRIC PORTFOLIO ASSOCIATES LLC 2021-03-31 33960
MILLENNIUM MANAGEMENT LLC 2021-03-31 83018
STRS OHIO 2021-06-30 2000
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 2021-06-30 1100000
ROYAL BANK OF CANADA (RY, RY-PT, RYMTF) 2021-03-31 1138

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Commonwealth Trust 2021-05-31 18264 Long
Fidelity Mt Vernon Street Trust 2021-05-31 114272 Long
Fidelity Concord Street Trust 2021-05-31 7514 Long
Fidelity Salem Street Trust 2021-04-30 57751 Long
FIDELITY COVINGTON TRUST 2021-04-30 4392 Long

Insider trading for Inhibrx, Inc

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1766477 Wagner Klaus W. 2021-02-17 SALE Accept Accept Accept Accept

Inhibrx, Inc Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.


On-Balance Volume information for Inhibrx, Inc. On-Balance Volume information can be an indicator for bullish or bearish outcome.


Accumulation / Distribution (A/D) indicator information for Inhibrx, Inc. The indicator identify divergences between price and volume flow.


Aroon Oscillator information for Inhibrx, Inc. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.


Average Directional Index (ADX) information for Inhibrx, Inc. The index can be used to identify the strengh of a trend.


Moving Average Convergence Divergence (MACD) for Inhibrx, Inc. The indicator helps to predict trend direction and the momentum of the trend.


Stochastic Oscillator as momentum indicator for Inhibrx, Inc. The indicator is useful for identifying overbought and oversold levels.


Relative Strength Index (RSI) for Inhibrx, Inc. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].


52W High 52W Low Market Cap

Similar shares


Inhibrx, Inc on Nasdaq

Inhibrx, Inc on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2021-11-01 35.72 2021-10-23 05:35
2021-11-02 36.16 2021-10-23 05:35
2021-11-03 36.11 2021-10-23 05:35
2021-11-04 36.25 2021-10-23 05:35
2021-11-05 37.06 2021-10-23 05:35
2021-11-08 37.25 2021-10-23 05:35
2021-11-09 36.92 2021-10-23 05:35
2021-10-25 36.69 2021-10-23 05:35
2021-10-26 35.39 2021-10-23 05:35
2021-10-27 34.88 2021-10-23 05:35
2021-10-28 34.77 2021-10-23 05:35
2021-10-29 35.20 2021-10-23 05:35
2021-11-10 36.41 2021-10-23 05:35
2021-11-11 36.11 2021-10-23 05:35
2021-11-12 35.58 2021-10-23 05:35
2021-11-15 34.43 2021-10-23 05:35
2021-11-16 34.19 2021-10-23 05:35
2021-11-17 34.38 2021-10-23 05:35
2021-11-18 33.68 2021-10-23 05:35
2021-11-19 33.43 2021-10-23 05:35
2021-11-22 33.35 2021-10-23 05:35
2021-11-23 33.35 2021-10-23 05:35
2021-11-24 33.43 2021-10-23 05:35
2021-11-25 33.43 2021-10-23 05:35
2021-11-26 33.47 2021-10-23 05:35
2021-11-29 33.25 2021-10-23 05:35
2021-11-30 33.02 2021-10-23 05:35
2021-12-01 32.94 2021-10-23 05:35
2021-12-02 32.67 2021-10-23 05:35
2021-12-03 32.33 2021-10-23 05:35
2021-12-06 32.07 2021-10-23 05:35
2021-12-07 31.89 2021-10-23 05:35
2021-12-08 31.55 2021-10-23 05:35
2021-12-09 31.19 2021-10-23 05:35
2021-12-10 31.23 2021-10-23 05:35
2021-12-13 31.17 2021-10-23 05:35
2021-12-14 30.95 2021-10-23 05:35
2021-12-15 30.92 2021-10-23 05:35
2021-12-16 30.87 2021-10-23 05:35
2021-12-17 30.81 2021-10-23 05:35